MYUNGMOON Pharm co.,Ltd (KRX:017180)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,283.00
-37.00 (-2.80%)
Jun 10, 2026, 3:30 PM KST
Market Cap42.89B -22.2%
Revenue (ttm)197.37B +4.9%
Net Income3.03B
EPS90.44
Shares Out 33.43M
PE Ratio14.19
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume91,506
Open1,330.00
Previous Close1,320.00
Day's Range1,265.00 - 1,331.00
52-Week Range1,276.00 - 2,055.00
Beta0.23
Analystsn/a
Price Targetn/a
Earnings DateMay 28, 2026

About MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics,... [Read more]

Sector Healthcare
Founded 1983
Employees 291
Stock Exchange Korea Stock Exchange
Ticker Symbol 017180
Full Company Profile

Financial Performance

Financial Statements